WONOEP appraisal: Targeted therapy development for early onset epilepsies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCasillas\\-Espinosa, Pablo M.
dc.contributor.authorWong, Jennifer C.
dc.contributor.authorGrabon, Wanda
dc.contributor.authorGonzalez\\-Ramos, Ana
dc.contributor.authorMantegazza, Massimo
dc.contributor.authorYilmaz, Nihan Carcak
dc.contributor.authorPatel, Manisha
dc.contributor.authorStaley, Kevin
dc.contributor.authorSankar, Raman
dc.contributor.authorO'Brien, Terence J.
dc.contributor.authorAkman, Ozlem
dc.contributor.authorBalagura, Ganna
dc.contributor.authorNumis, Adam L.
dc.contributor.authorNoebels, Jeffrey L.
dc.contributor.authorBaulac, Stephanie
dc.contributor.authorAuvin, Stephane
dc.contributor.authorHenshall, David C.
dc.contributor.authorGalanopoulou, Aristea S.
dc.date.accessioned2025-10-16T15:12:25Z
dc.date.issued2025
dc.identifier.doi10.1111/epi.18187
dc.identifier.otherWOS:001357990100001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5431
dc.publisherWILEY
dc.sourceEPILEPSIA
dc.subjectacetylcholinesterase
dc.subjectbumetanide
dc.subjectcannabidiol
dc.subjectcannabinoid receptor type 2
dc.subjectdevelopmental and epileptic encephalopathies
dc.subjectinterneuron
dc.subjectmiRNA
dc.subjectorexin
dc.titleWONOEP appraisal: Targeted therapy development for early onset epilepsies
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS